Named based on the expression of previously established marker genes ERBB2 (T062), NTRK1 (T063), MYCN (T064) and TERT (T065), these subtypes may be rooted in the tumor’s lineage43–45 (Fig. 5g). This evidence concerns the gene MYCN and neoplasm.